Kinegic Pharmaceuticals was associated with 2 DSIR approved dedicated R&D setups with capabilities to develop safe and effective formulations. We has a team of over 50+ scientists working on development of varied dosage forms such as Injectables, Soft Gelatin Capsules, Oral Disintegrating Films, Effervescents, Gummies/Candies and Nutraceuticals.
Separate teams work on formulation development and analytical studies of molecules for Regulated and Emerging markets. R & D scale stability studies, forced degradation studies, method development and validations are carried out in house. Our R&D teams continue to grow in strength each year, taking on complex challenges across varied formulations.
Drugs include small molecules, antibodies, and other types of drug molecules, collectively called "modalities." With advances in science, a variety of modalities have allowed us to approach drug discovery targets that have been challenging to date. We are also conducting research on a variety of other modalities, and we are working on research and development with the aim of increasing the therapeutic potential of any treatment to patients with diseases for which no effective treatment is available until now, or those for which existing drugs do not provide sufficient efficacy.